SUBSCRIBE
SUBSCRIBE

Astria Therapeutics

NEWS
Business
BioSpace Movers & Shakers: Astria, Apertura, CytoDyn, IN8bio & More Make Big Moves
New leaders and top executive roles were selected to guide biopharma and life science companies from Apertura Gene Therapy to CytoDyn, Vaccentis AG, Suvoda LLC, IN8bio and more.
July 14, 2022
 · 
9 min read
 · 
Alex Keown
JOBS
IN THE PRESS
Genetown
Astria Therapeutics to Participate in Upcoming Investor Conferences
September 6, 2023
 · 
1 min read
Drug Development
Astria Therapeutics Announces Publication of STAR-0215 Preclinical Data in the Journal of Pharmacology and Experimental Therapeutics
August 31, 2023
 · 
7 min read
Genetown
Astria Therapeutics to Present Patient Survey Data at Upcoming 2023 HAEi Regional EMEA Conference
August 25, 2023
 · 
1 min read
Business
Astria Therapeutics Reports Second Quarter Financial Results and Provides a Corporate Update
August 7, 2023
 · 
12 min read
Genetown
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - August 02, 2023
August 2, 2023
 · 
1 min read
FDA
Astria Therapeutics Receives Fast Track Designation for STAR-0215 for the Treatment of Hereditary Angioedema
July 20, 2023
 · 
7 min read
Business
Astria Therapeutics Names John Ruesch as Senior Vice President, Pharmaceutical Sciences and Technical Operations
July 17, 2023
 · 
6 min read
Genetown
Astria Therapeutics to Present Patient Survey Data at Upcoming 2023 US HAEA National Summit
July 14, 2023
 · 
1 min read
Genetown
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - July 06, 2023
July 6, 2023
 · 
1 min read
Deals
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - June 6, 2023
June 6, 2023
 · 
1 min read
Load More